Tuberculosis diagnosis in resource-limited settings: Clinical use of GeneXpert in the diagnosis of smear-negative PTB: A case report

African Health Sciences

Volumn 13, Issue 2, 2013, Pages 522-524

  Nakiyingi, Lydia ^a   Nankabirwa, H ^a   Lamorde, M ^a  

^a MAKERERE UNIVERSITY   (Uganda)

Author keywords

Developing countries; Molecular diagnostic techniques; Tuberculosis

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; COTRIMOXAZOLE; EFAVIRENZ; EMTRICITABINE; RIFAMPICIN; TENOFOVIR DISOPROXIL;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL LOAD; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL PRACTICE; DELAYED DIAGNOSIS; DIAGNOSTIC EQUIPMENT; ERYTHROCYTE SEDIMENTATION RATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPENIA; LUNG TUBERCULOSIS; MALE; MOLECULAR DIAGNOSIS; MYCOBACTERIUM TUBERCULOSIS; SPUTUM CYTODIAGNOSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY;

DEVELOPING COUNTRIES; MOLECULAR DIAGNOSTIC TECHNIQUES; TUBERCULOSIS;

AUTOMATION, LABORATORY; DIAGNOSTIC TESTS, ROUTINE; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY; UGANDA;

EID: 84883669370     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v13i2.46     Document Type: Article

References (9)

1. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007;369(9578):2042-9.
2. Lawn SD, Wood R. Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis. 2011;204 Suppl 4:S1159-67.
3. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48(1):229-37.
4. Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010;48(7):2495-501.
5. Van Rie A, Page-Shipp L, Scott L, Sanne I, Stevens W. Xpert(R) MTB/RIF for point-ofcare diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diagn. 2010;10(7):937-46.
6. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011 Apr 30;377(9776):1495-505.
7. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, et al. Screening for HIVassociated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med. 2011 Jul;8(7):e1001067.
8. Rachow A, Zumla A, Heinrich N, Rojas-Ponce G, Mtafya B, Reither K, et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay-a clinical validation study. PLoS One. 2011;6(6):e20458.
9. Lawn SD, Nicol MP. Xpert(R) MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011 Sep;6(9):1067-82.